BC
BSX icon

Barrett & Company’s Boston Scientific BSX Stock Holding History

Barrett & Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Hold
42
– – ﹤0.01% 631
2026
Q1 		$2.64K Hold
42
– – ﹤0.01% 567
2025
Q4 		$4K Sell
42
-3,400
-99% -$333K ﹤0.01% 547
2025
Q3 		$336K Sell
3,442
-800
-19% -$82.8K 0.12% 102
2025
Q2 		$456K Hold
4,242
– – 0.17% 88
2025
Q1 		$428K Hold
4,242
– – 0.18% 87
2024
Q4 		$379K Buy
+4,242
New +$373K 0.16% 90

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barrett & Company's BSX Position: Q2 2026 in Review

Barrett & Company held its Boston Scientific (BSX) position steady in Q2 2026 at 42 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #631.

Barrett & Company first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $456K in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Barrett & Company held 42 shares of Boston Scientific worth $1.79K as of Q2 2026.
  • Barrett & Company left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #631 holding.
  • Barrett & Company first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Barrett & Company's Boston Scientific position peaked at $456K in Q2 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.